For years, I've been earning easy rewards with two Motley Fool Money award-winning cards. Here's why I'm still sticking with ...

The sale of 30 million shares valued the firm at US$5.41 billion, with its US offering priced above guidance at US$37.

Merck’s second quarter performance aligned with Wall Street’s revenue expectations but drew a negative reaction from the ...

Investing globally is not without risk, but with so much uncertainty in the world right now, spreading your bets across the globe could be just what the doctor ordered. Each of these three ETFs ...

Crypto exchange Bullish priced its IPO at $37 per share, above its expected range, giving it a market value of over $5 ...

Incyte’s second quarter was marked by broad-based strength across its commercial portfolio, reflected in a significant ...

Remote and hybrid work became the norm after the COVID-19 pandemic, but more workplaces, like Amazon, JPMorgan Chase, Disney ...